Corticosteroids are cornerstone anti-inflammatory agents widely used in the management of various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and acute respiratory distress syndrome (ARDS). Their therapeutic effectiveness stems from their ability to suppress airway inflammation, reduce immune responses, and improve respiratory function. Despite their established role, concerns remain regarding their optimal use, long-term safety, and adherence to clinical guidelines. The objective of this survey-based study was to evaluate current patterns of corticosteroid use in respiratory conditions among healthcare professionals and patients, assess the perceived effectiveness and side effect profile, and identify trends, gaps, and inconsistencies in their administration. The survey was conducted among a diverse group of clinicians and patients across multiple healthcare settings, employing structured questionnaires and patient interviews. Key findings revealed that inhaled corticosteroids remain the most commonly prescribed form, particularly in asthma and mild-to-moderate COPD, while systemic corticosteroids are frequently used during exacerbations and in severe cases. A significant proportion of clinicians reported deviation from standard treatment guidelines due to factors such as patient non-compliance, economic constraints, or clinical judgment. Patients expressed mixed responses regarding long-term corticosteroid use, with concerns about side effects like weight gain, osteoporosis, and immunosuppression being common. The survey also identified a need for increased awareness about corticosteroid tapering and monitoring strategies. In conclusion, while corticosteroids continue to play a vital role in respiratory therapy, the survey highlights the necessity for improved guideline adherence, patient education, and monitoring practices to enhance therapeutic outcomes and minimize adverse effects. These findings suggest the need for targeted interventions and further clinical training to bridge knowledge-practice gaps and promote rational corticosteroid use in respiratory care.